Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
12 2021
Historique:
received: 10 03 2021
revised: 09 07 2021
accepted: 26 07 2021
pubmed: 2 8 2021
medline: 26 10 2021
entrez: 1 8 2021
Statut: ppublish

Résumé

X-linked hypophosphatemic rickets (XLH) is an inheritable type of rickets caused by inactivating variants in the phosphate regulating endopeptidase homolog X-linked (PHEX) gene, which results in the overproduction of fibroblast growth factor 23 (FGF23). The mechanism by which PHEX impairment leads to FGF23 overproduction is unknown. Because little is known regarding the genotype-phenotype correlation in Japanese XLH, we summarized the available clinical and genetic data and analyzed the genotype-phenotype relationships using 3-dimensional (3D) structure modeling to clarify the XLH pathophysiology. We retrospectively reviewed the clinical features and performed genetic analysis of 39 Japanese patients with XLH from 28 unrelated pedigrees carrying any known or novel PHEX variant. To predict changes in the 3D structure of mutant PHEX, we constructed a putative 3D model of each mutant and evaluated the effect of structural alteration by genotype-phenotype correlation analysis. Genetic analysis revealed 23 PHEX variants, including eight novel variants. They were associated with high i-FGF23 levels, hypophosphatemia, phosphaturia, high alkaline phosphatase levels, and short stature. No gene dosage effect or genotype-phenotype correlation was observed when truncating and non-truncating variants were compared. However, the conservation of the zinc-binding site and cavity in PHEX had an impact on the elevation of i-FGF23 levels. Via genotype-phenotype relationship analysis using 3D modeling, we showed that the zinc-binding site and cavity in PHEX can play a critical role in its function. These findings provide new genetic clues for investigating the function of PHEX and the pathogenesis of XLH.

Identifiants

pubmed: 34333162
pii: S8756-3282(21)00300-8
doi: 10.1016/j.bone.2021.116135
pii:
doi:

Substances chimiques

FGF23 protein, human 0
Fibroblast Growth Factors 62031-54-3
Fibroblast Growth Factor-23 7Q7P4S7RRE
PHEX Phosphate Regulating Neutral Endopeptidase EC 3.4.24.-
PHEX protein, human EC 3.4.24.-
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116135

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Yasuki Ishihara (Y)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan; The 1st. Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Suita, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Yasuhisa Ohata (Y)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Shinji Takeyari (S)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Taichi Kitaoka (T)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Makoto Fujiwara (M)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan; The 1st. Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Suita, Japan.

Yukako Nakano (Y)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Kenichi Yamamoto (K)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan; Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.

Chieko Yamada (C)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Katsusuke Yamamoto (K)

Department of Pediatric Nephrology and Metabolism, Osaka Women's and Children's Hospital, Izumi, Japan.

Toshimi Michigami (T)

Department of Bone and Mineral Research, Osaka Women's and Children's Hospital, Izumi, Japan.

Hiroyo Mabe (H)

Department of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.

Takeshi Yamaguchi (T)

Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Katsuyuki Matsui (K)

Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.

Izumi Tamada (I)

Department of Pediatrics, Imakiire General Hospital, Kagoshima, Japan.

Noriyuki Namba (N)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Tottori, Japan.

Akiko Yamamoto (A)

Department of Pediatrics, Kumamoto Chuo Hospital, Kumamoto, Japan.

Junya Etoh (J)

Department of Pediatrics, Saga-Ken Medical Centre Koseikan, Saga, Japan.

Azusa Kawaguchi (A)

Department of Pediatrics, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.

Rieko Kosugi (R)

Department of Diabetes and Endocrinology, Shizuoka General Hospital, Shizuoka, Japan.

Keiichi Ozono (K)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.

Takuo Kubota (T)

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan. Electronic address: tkubota@ped.med.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH